Vaccine Therapy in Treating Patients With Malignant Melanoma
Phase 2
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2005-08-10
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- CancerVax Corporation
- Registration Number
- NCT00128583
- Locations
- ๐บ๐ธ
Simmons Cancer Center at University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
๐ฆ๐บSydney Cancer Centre at Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
๐บ๐ธLakeland Regional Cancer Center at Lakeland Regional Medical Center, Lakeland, Florida, United States
Vaccine Therapy for Patients With Stage III Melanoma
Phase 3
- Conditions
- Malignant Melanoma
- First Posted Date
- 2003-01-24
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- CancerVax Corporation
- Target Recruit Count
- 1118
- Registration Number
- NCT00052130
- Locations
- ๐บ๐ธ
Cedars Sinai Comprehensive Cancer Center, Los Angeles, California, United States
๐บ๐ธEllis Fischel Cancer Center - Columbia, Columbia, Missouri, United States
๐บ๐ธFox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Vaccine Therapy for Patients With Stage IV Melanoma
Phase 3
- Conditions
- Malignant Melanoma
- First Posted Date
- 2003-01-24
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- CancerVax Corporation
- Target Recruit Count
- 670
- Registration Number
- NCT00052156
- Locations
- ๐บ๐ธ
Loyola University Medical Center, Maywood, Illinois, United States
๐บ๐ธEllis Fischel Cancer Center - Columbia, Columbia, Missouri, United States
๐บ๐ธUniversity of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath